DevicePMAs@therightstef:P010012_S026 / 214-227
|
Approval for the contak cd, contak cd 2, renewal, and renewal 3 devices. These devices are indicated for patients with moderate to severe heart failure (nyha iii/iv) who remain symptomatic despite stable, optimal heart failure drug therapy and have left ventricular dysfunction (ef <= 35%) and qrs duration >= 120 ms.
|
projects
| Unselected / annnotation | Selected / annnotation | |
|
|
|
|